GR78822B - - Google Patents

Info

Publication number
GR78822B
GR78822B GR71026A GR830171026A GR78822B GR 78822 B GR78822 B GR 78822B GR 71026 A GR71026 A GR 71026A GR 830171026 A GR830171026 A GR 830171026A GR 78822 B GR78822 B GR 78822B
Authority
GR
Greece
Application number
GR71026A
Other languages
Greek (el)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GR78822B publication Critical patent/GR78822B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR71026A 1982-04-08 1983-04-07 GR78822B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36662782A 1982-04-08 1982-04-08

Publications (1)

Publication Number Publication Date
GR78822B true GR78822B (xx) 1984-10-02

Family

ID=23443823

Family Applications (1)

Application Number Title Priority Date Filing Date
GR71026A GR78822B (xx) 1982-04-08 1983-04-07

Country Status (25)

Country Link
JP (1) JPS58188887A (xx)
KR (1) KR880001055B1 (xx)
AT (1) AT383126B (xx)
AU (1) AU567092B2 (xx)
BE (1) BE896407A (xx)
CA (1) CA1198440A (xx)
CH (1) CH661927A5 (xx)
DE (1) DE3312517A1 (xx)
DK (1) DK155983A (xx)
ES (1) ES521224A0 (xx)
FI (1) FI74009C (xx)
FR (1) FR2524888B1 (xx)
GB (1) GB2118183B (xx)
GR (1) GR78822B (xx)
HU (1) HU190716B (xx)
IE (1) IE55225B1 (xx)
IL (1) IL68295A0 (xx)
IT (1) IT1168854B (xx)
LU (1) LU84739A1 (xx)
MY (1) MY8700945A (xx)
NL (1) NL8301193A (xx)
OA (1) OA07395A (xx)
PT (1) PT76518B (xx)
SE (1) SE460197B (xx)
ZA (1) ZA832411B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
AT396473B (de) * 1984-10-02 1993-09-27 Bristol Myers Squibb Co Verfahren zur herstellung von neuen carbapenemderivaten
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
HU185493B (en) * 1981-12-30 1985-02-28 Richter Gedeon Vegyeszet Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptene derivatives
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics

Also Published As

Publication number Publication date
ZA832411B (en) 1983-12-28
PT76518B (en) 1986-02-06
AU1319883A (en) 1983-10-13
SE8301928L (sv) 1983-12-02
MY8700945A (en) 1987-12-31
IL68295A0 (en) 1983-07-31
CA1198440A (en) 1985-12-24
IT8348061A0 (it) 1983-04-07
IE830800L (en) 1983-10-08
AT383126B (de) 1987-05-25
GB2118183A (en) 1983-10-26
IE55225B1 (en) 1990-07-04
KR880001055B1 (ko) 1988-06-18
DK155983D0 (da) 1983-04-07
SE460197B (sv) 1989-09-18
GB2118183B (en) 1985-11-27
FI74009B (fi) 1987-08-31
DE3312517C2 (xx) 1991-10-31
PT76518A (en) 1983-05-01
CH661927A5 (de) 1987-08-31
FI74009C (fi) 1987-12-10
JPS58188887A (ja) 1983-11-04
BE896407A (fr) 1983-10-07
OA07395A (fr) 1984-06-30
FR2524888B1 (fr) 1985-12-13
HU190716B (en) 1986-10-28
JPH0524156B2 (xx) 1993-04-06
SE8301928D0 (sv) 1983-04-07
FI831135A0 (fi) 1983-04-05
ES8405399A1 (es) 1984-06-01
ES521224A0 (es) 1984-06-01
FI831135L (fi) 1983-10-09
DE3312517A1 (de) 1983-10-20
FR2524888A1 (fr) 1983-10-14
NL8301193A (nl) 1983-11-01
ATA125583A (de) 1986-10-15
DK155983A (da) 1983-10-09
LU84739A1 (fr) 1983-12-05
GB8309505D0 (en) 1983-05-11
AU567092B2 (en) 1987-11-12
KR840004429A (ko) 1984-10-15
IT1168854B (it) 1987-05-20

Similar Documents

Publication Publication Date Title
FR2525055B1 (xx)
DE3329907C2 (xx)
DE3347932C2 (xx)
DE3333291C2 (xx)
FR2522769B1 (xx)
DE3311048C2 (xx)
DE3228378C2 (xx)
FR2525194B1 (xx)
DE3227770C2 (xx)
DE3304995C2 (xx)
FR2521939B3 (xx)
CH665521GA3 (xx)
FR2522823B1 (xx)
FR2521445B3 (xx)
DE3332051C2 (xx)
DE3215635C2 (xx)
DE3343572C2 (xx)
DE3246577C2 (xx)
FR2520607B3 (xx)
FR2519809B1 (xx)
DE3324732C2 (xx)
DE3303493C2 (xx)
DE3213413C2 (xx)
FR2525020B1 (xx)
FR2523501B1 (xx)